The global GPCR Assay Services market size is predicted to grow from US$ 794 million in 2025 to US$ 1175 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.

GPCR assay services refer to the specialized laboratory services offered by contract research organizations (CROs) or research facilities to conduct assays and experiments related to G Protein-Coupled Receptors (GPCRs). These services are commonly used in drug discovery and pharmacological research to assess the activity of GPCRs and identify potential drug candidates that can interact with these receptors. GPCRs are a large family of cell membrane proteins involved in a wide range of physiological processes, and they are targets for a significant portion of pharmaceutical drugs.

Growth in Drug Discovery: The pharmaceutical industry continued to invest in drug discovery, and GPCR targets remained a significant focus due to their involvement in various diseases and physiological processes. This drove demand for GPCR assay services to identify potential drug candidates.

High-Throughput Screening (HTS): The use of high-throughput screening techniques in GPCR assays was on the rise. HTS allows researchers to rapidly test large compound libraries, accelerating the drug discovery process.

Biophysical Assays: There was an increasing emphasis on developing biophysical assays that provide insights into GPCR conformational changes and interactions with ligands. These assays are critical for understanding receptor behavior and drug binding.

Functional Assays: GPCR assay services continued to evolve with a focus on functional assays that assess the signaling pathways activated by GPCRs upon ligand binding. This included the use of more physiologically relevant cell-based assays.

LPI (LP Information) newest research report, the ?GPCR Assay Services Industry Forecast? looks at past sales and reviews total world GPCR Assay Services sales in 2024, providing a comprehensive analysis by region and market sector of projected GPCR Assay Services sales for 2025 through 2031. With GPCR Assay Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GPCR Assay Services industry.

This Insight Report provides a comprehensive analysis of the global GPCR Assay Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GPCR Assay Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global GPCR Assay Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GPCR Assay Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GPCR Assay Services.

This report presents a comprehensive overview, market shares, and growth opportunities of GPCR Assay Services market by product type, application, key players and key regions and countries.

Segmentation by Type:

    ?-arrestin Recruitment
    Ca2+
    cAMP
    DAG

Segmentation by Application:

    Oncology
    Cardiovascular System
    Central Nervous System
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.

    Thermo Fisher Scientific
    PerkinElmer
    Merck
    Molecular Devices
    Promega
    Cisbio
    Discoverx
    Enzo Life Sciences
    Pharmaron
    Innoprot
    Euroscreen
    ArcoScreen
    Profacgen
    Creative BioMart
    Hamamatsu Photonics
    Reaction Biology